Sir Mark Walport debunks ‘myth’ that he is pushing research agenda
Chief scientific adviser is ‘amused’ by funding conspiracy theories but dismisses them as ‘complete invention’

Chief scientific adviser is ‘amused’ by funding conspiracy theories but dismisses them as ‘complete invention’

Japan loses its crown to its main regional rival, as massive state funding and innovation pay dividends for the People’s Republic, writes Katie Duncan

Nearing its half-century, the Science Policy Research Unit’s bold bid to find ‘radical solutions’ to global problems will cast the expertise net wide

Plans are part of industrial strategy to steal a march on other export-driven countries

The 2015 Times Higher Education World Academic Summit will take place in Melbourne, Australia, in partnership with the University of Melbourne, it was announced today

Filming in what they believed were Wilko Johnson’s final days, the guitarist and the director offer up a celebratory vision of culture and life, writes Andrew Blake

United StatesMobile phones: the ‘invisible addiction’Female students in the US spend an average of 10 hours a day on their mobile phone, while their male counterparts rack up nearly eight, a study at...

Those studying at Arizona State and other universities are in demand as firms across the US seek fresh business insights, says Jon Marcus

Bankers swap cufflinks for cassocks in an era of reinvention not defined by pay, finds Leslie Gofton

Quality assuranceQAA heads to the MedUK higher education provision in Cyprus, Greece and Malta is to be reviewed by the Quality Assurance Agency. More than 20,000 students are enrolled in UK higher...

Economist Andrew Oswald counsels against despair over the Universities Superannuation Scheme reforms
Businesses must have a more effective input into the design and delivery of courses at undergraduate, postgraduate and foundation level, according to Universities UK's submission to the Treasury-...

Despite the introduction of postgraduate loans, the government’s education funding aims remain a puzzle, says Nigel Carrington

Life sciences ecosystem may lose out if US firm was ever to take over Anglo-Swedish pharmaceutical company AstraZeneca